Medical Device Security: FDA Cybersecurity & IoMT
We help medical device manufacturers build security programs that meet FDA cybersecurity requirements, secure connected devices, protect patient safety, and support product launches. Our expertise spans premarket FDA submissions and postmarket security management.
Why Medical Device Security Matters
Medical device security isn't just a compliance checkbox—it's a patient safety issue. FDA increasingly scrutinizes cybersecurity controls for medical devices, connected devices, and Internet of Medical Things (IoMT) products.
FDA Premarket Cybersecurity Requirements
FDA guidance and rules (like the final Premarket Cybersecurity guidance) require device manufacturers to address cybersecurity threats during device design and development. You need to demonstrate: threat modeling, vulnerability assessment, secure design practices, secure software development, and a plan for postmarket management. Missing these controls delays approval and puts your product at risk.
Postmarket Cybersecurity Management
After FDA clearance, you're required to monitor for vulnerabilities, manage discovered issues through coordinated disclosure, and implement patches or mitigations. The FDA expects documented processes for vulnerability disclosure, tracking, and resolution. Failures here trigger regulatory action and damage patient trust.
IoMT and Connected Device Security
Connected medical devices introduce new attack surfaces. Devices that communicate with hospital networks, cloud platforms, mobile apps, or other systems need secure protocols, authentication mechanisms, and network segmentation. IoMT vulnerabilities can compromise entire hospital ecosystems and patient safety systems.
Device Vulnerability Disclosure Programs
FDA now expects manufacturers to have coordinated vulnerability disclosure programs. You need a process to accept security research reports, investigate issues responsibly, and work with security researchers and healthcare providers. Mishandling vulnerability disclosures creates regulatory problems and damages your reputation.
Product Security Lifecycle
Medical device security spans the entire product lifecycle: premarket design and testing, launch and monitoring, ongoing vulnerability management, end-of-life support, and replacement planning. Each phase has specific FDA expectations and patient safety implications.
When to Engage Medical Device Security Expertise
You need medical device security expertise at multiple points in your product development:
Preparing FDA Submission with Cybersecurity Documentation
- Developing threat models and vulnerability assessments for FDA submission
- Building evidence of secure design practices throughout development
- Creating security documentation that satisfies FDA expectations
- Pre-submission meetings with FDA on cybersecurity approach
Building Connected Medical Devices
- Designing secure communication for IoMT and connected devices
- Implementing authentication and encryption in device firmware
- Securing cloud backends and mobile apps for device management
- Planning for secure updates and patch deployment
Need FDA Cybersecurity Assessment
- Evaluating existing device designs against FDA guidance
- Assessing threat models and control effectiveness
- Identifying gaps before formal FDA submission
- Planning remediation for security weaknesses
Postmarket Vulnerability Management
- Setting up vulnerability disclosure programs
- Creating processes for reporting and tracking device vulnerabilities
- Managing coordinated disclosure with security researchers
- Implementing and deploying security patches
MDR Compliance and Incident Response
- Managing Medical Device Reporting (MDR) for security incidents
- Responding to FDA inquiries about device vulnerabilities
- Creating incident response plans for security breaches
- Documenting postmarket security surveillance
How We Help Medical Device Manufacturers
FDA Premarket Cybersecurity Documentation
We help you build the security documentation FDA wants to see: threat models that identify realistic attack scenarios, vulnerability assessments showing how your controls mitigate those threats, and secure development evidence. We ensure your submissions are thorough, credible, and accelerate FDA review.
Threat Modeling for Medical Devices
We work with your engineering teams to develop device-specific threat models that identify plausible attack scenarios based on device design, connectivity, and clinical use. These models guide control implementation and satisfy FDA expectations for understanding your attack surface.
IoMT Security Architecture
For connected devices, we help design secure architectures that address healthcare network realities: hospital firewalls, network segmentation, cloud connectivity, and mobile apps. This includes secure boot, firmware integrity verification, secure communication protocols, and secure configuration management.
Vulnerability Disclosure Programs
We help establish coordinated vulnerability disclosure programs that work with security researchers ethically, investigate reported vulnerabilities properly, and deploy fixes responsibly. This protects patients, satisfies FDA expectations, and builds trust with the security community.
Postmarket Cybersecurity Management
We help you establish processes for ongoing vulnerability monitoring, risk assessment, patch development and testing, deployment coordination with customers (hospitals, clinicians), and FDA communication. Postmarket management is continuous, not one-time.
Common Questions About Medical Device Security
What are FDA's premarket cybersecurity requirements for medical devices?
FDA's Premarket Cybersecurity Guidance requires manufacturers to conduct threat modeling, assess vulnerabilities, implement appropriate security controls during design and development, and demonstrate secure software development practices. You must document how your device design addresses identified cybersecurity threats and how you'll manage security postmarket. For 510(k) submissions, cybersecurity documentation is increasingly critical.
What postmarket cybersecurity guidance does FDA provide?
FDA's Postmarket Cybersecurity Guidance expects manufacturers to monitor for vulnerabilities, assess identified threats, and implement patches or mitigations as appropriate. You need a documented process for vulnerability disclosure, tracking, and management. FDA also expects you to communicate security updates to customers (hospitals, clinicians) and keep informed about emerging threats in your device's ecosystem.
How should medical device manufacturers handle coordinated vulnerability disclosure?
FDA expects manufacturers to establish processes for accepting vulnerability reports from security researchers, investigating reports responsibly, and working with researchers on timeline and solutions. Best practices include publishing a vulnerability disclosure policy, maintaining contact information for security researchers, responding to reports promptly, and coordinating patch deployment. Responsible disclosure protects patients and demonstrates FDA compliance.
How do we test device security before FDA submission?
Device security testing should include threat modeling validation (testing that your assumptions about attacks are realistic), vulnerability assessments (identifying security weaknesses in design and implementation), penetration testing (attempting to exploit vulnerabilities), and secure configuration testing. Test results should feed back into design improvements and be documented for FDA. Consider involving independent security testing for credibility.
Have more questions?
View all frequently asked questionsRelated Healthcare & Life Sciences Services
Ready to Strengthen Your Medical Device Security?
Let's discuss your FDA cybersecurity requirements, connected device security, and product launch timelines.